Bellevue Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-610,000	Closed	-$28.7M	–	162
2024 Q3	$28.7M	Sell	610,000 -7,649	-1%	-$359K	0.46%	63
2024 Q2	$33.4M	Sell	617,649 -2,301	-0.4%	-$124K	0.54%	53
2024 Q1	$42.3M	Sell	619,950 -280,450	-31%	-$19.1M	0.64%	49
2023 Q4	$56.4M	Buy	900,400 +2,000	+0.2%	+$125K	0.86%	34
2023 Q3	$40.8M	Sell	898,400 -900	-0.1%	-$40.9K	0.66%	47
2023 Q2	$50.5M	Sell	899,300 -500	-0.1%	-$28.1K	0.72%	45
2023 Q1	$40.7M	Sell	899,800 -11,905	-1%	-$538K	0.59%	53
2022 Q4	$37.1M	Sell	911,705 -16,600	-2%	-$675K	0.49%	61
2022 Q3	$60.7M	Buy	928,305 +6,300	+0.7%	+$412K	0.87%	39
2022 Q2	$56M	Sell	922,005 -4,900	-0.5%	-$298K	0.79%	41
2022 Q1	$58.2M	Sell	926,905 -47,779	-5%	-$3M	0.68%	52
2021 Q4	$73.9M	Hold	974,684	–	–	0.76%	45
2021 Q3	$109M	Buy	974,684 +7,800	+0.8%	+$873K	1.11%	28
2021 Q2	$157M	Sell	966,884 -11,500	-1%	-$1.86M	1.53%	16
2021 Q1	$119M	Buy	978,384 +68,700	+8%	+$8.37M	1.26%	24
2020 Q4	$139M	Sell	909,684 -39,578	-4%	-$6.06M	1.6%	15
2020 Q3	$79.4M	Buy	949,262 +148,800	+19%	+$12.4M	1.1%	27
2020 Q2	$58.8M	Hold	800,462	–	–	0.83%	35
2020 Q1	$33.9M	Buy	800,462 +70,000	+10%	+$2.97M	0.66%	43
2019 Q4	$44.5M	Sell	730,462 -106,700	-13%	-$6.5M	0.71%	41
2019 Q3	$34.3M	Buy	837,162 +26,700	+3%	+$1.09M	0.64%	42
2019 Q2	$38.2M	Buy	+810,462	New	+$38.2M	0.65%	40